Search results
Results from the Health.Zone Content Network
Von Hippel–Lindau disease ( VHL ), also known as Von Hippel–Lindau syndrome, is a rare genetic disorder with multisystem involvement. [3] It is characterized by visceral cysts and benign tumors with potential for subsequent malignant transformation. It is a type of phakomatosis that results from a mutation in the Von Hippel–Lindau tumor ...
Some common symptoms of VHL disease include: headaches. poor balance. dizziness. weakness in your limbs. hearing loss in one ear. high blood pressure. The onset of symptoms from VHL disease can ...
The Von Hippel–Lindau tumor suppressor also known as pVHL is a protein that, in humans, is encoded by the VHL gene. Mutations of the VHL gene are associated with Von Hippel–Lindau disease, which is characterized by hemangioblastomas of the brain, spinal cord and retina. It is also associated with kidney and pancreatic lesions.
Official website. www .vhlru .ru /en /. The All-Russian Hockey League (VHL) [1] [2] (Russian: Всероссийская хоккейная лига (ВХЛ), Vserossiyskaya hokkeinaya liga (VHL) ), also known as the Major Hockey League [3] [4] or Higher Hockey League ( HHL ), [5] is a professional ice hockey league in Eurasia, and the second ...
A study found that elevated levels of C-reactive protein were linked to a three times greater risk of a heart attack. Here are what the results mean: hs-CRP level lower than 1.0 milligrams per ...
Oncology. Hemangioblastomas, or haemangioblastomas, are vascular tumors of the central nervous system that originate from the vascular system, usually during middle age. Sometimes, these tumors occur in other sites such as the spinal cord and retina. [1] They may be associated with other diseases such as polycythemia (increased blood cell count ...
160 or higher; 190 is considered very high. 200 or higher; 500 is considered very high. Low. n/a. less than 40 for men and less than 50 for women. n/a. n/a. Guidelines are similar for males and ...
Central pattern generators also contribute to locomotion in humans. In 1994, Calancie, et al. described the "first well-defined example of a central rhythm generator for stepping in the adult human." The subject was a 37-year-old male who suffered an injury to the cervical spinal cord 17 years prior.